Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis
Linfeng Wang, Guangda Zheng, Yue Hu, Ayidana Maolan, Yue Luo, Yue Li et al. Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis. // BMC Pulmonary Medicine. – 2025. – DOI: 10.1186/s12890-025-03479-2. – URL: https://doi.org/10.1186/s12890-025-03479-2
Linfeng Wang, Guangda Zheng, Yue Hu, Ayidana Maolan, Yue Luo, Yue Li, & Rui Liu (2025). Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis. BMC Pulmonary Medicine. https://doi.org/10.1186/s12890-025-03479-2
Linfeng Wang, et al. “Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis.” BMC Pulmonary Medicine, 2025. doi:10.1186/s12890-025-03479-2.
@article{Wang2025,
title = {Comparative efficacy and safety of first-line neoadjuvant therapy for early-stage non-small cell lung cancer based on immune checkpoint inhibitor therapy: a systematic review and network meta-analysis},
author = {Wang, Linfeng and Zheng, Guangda and Hu, Yue and Maolan, Ayidana and Luo, Yue and Li, Yue and Liu, Rui},
journal = {BMC Pulmonary Medicine},
year = {2025},
doi = {10.1186/s12890-025-03479-2},
url = {https://doi.org/10.1186/s12890-025-03479-2}
}